| UniProt ID | ETV6_HUMAN | |
|---|---|---|
| UniProt AC | P41212 | |
| Protein Name | Transcription factor ETV6 | |
| Gene Name | ETV6 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 452 | |
| Subcellular Localization | Nucleus. | |
| Protein Description | Transcriptional repressor; binds to the DNA sequence 5'-CCGGAAGT-3'. Plays a role in hematopoiesis and malignant transformation.. | |
| Protein Sequence | MSETPAQCSIKQERISYTPPESPVPSYASSTPLHVPVPRALRMEEDSIRLPAHLRLQPIYWSRDDVAQWLKWAENEFSLRPIDSNTFEMNGKALLLLTKEDFRYRSPHSGDVLYELLQHILKQRKPRILFSPFFHPGNSIHTQPEVILHQNHEEDNCVQRTPRPSVDNVHHNPPTIELLHRSRSPITTNHRPSPDPEQRPLRSPLDNMIRRLSPAERAQGPRPHQENNHQESYPLSVSPMENNHCPASSESHPKPSSPRQESTRVIQLMPSPIMHPLILNPRHSVDFKQSRLSEDGLHREGKPINLSHREDLAYMNHIMVSVSPPEEHAMPIGRIADCRLLWDYVYQLLSDSRYENFIRWEDKESKIFRIVDPNGLARLWGNHKNRTNMTYEKMSRALRHYYKLNIIRKEPGQRLLFRFMKTPDEIMSGRTDRLEHLESQELDEQIYQEDEC | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Phosphorylation | ------MSETPAQCS ------CCCCCCCCC | 50.61 | 30108239 | |
| 4 | Phosphorylation | ----MSETPAQCSIK ----CCCCCCCCCCC | 19.33 | 30108239 | |
| 9 | Phosphorylation | SETPAQCSIKQERIS CCCCCCCCCCEEECC | 22.27 | 23401153 | |
| 11 | Sumoylation | TPAQCSIKQERISYT CCCCCCCCEEECCCC | 29.79 | - | |
| 11 | Acetylation | TPAQCSIKQERISYT CCCCCCCCEEECCCC | 29.79 | 19608861 | |
| 11 | Sumoylation | TPAQCSIKQERISYT CCCCCCCCEEECCCC | 29.79 | 28112733 | |
| 16 | Phosphorylation | SIKQERISYTPPESP CCCEEECCCCCCCCC | 29.22 | 22167270 | |
| 17 | Phosphorylation | IKQERISYTPPESPV CCEEECCCCCCCCCC | 22.39 | 22167270 | |
| 18 | Phosphorylation | KQERISYTPPESPVP CEEECCCCCCCCCCC | 26.10 | 22167270 | |
| 22 | Phosphorylation | ISYTPPESPVPSYAS CCCCCCCCCCCCCCC | 36.65 | 22167270 | |
| 26 | Phosphorylation | PPESPVPSYASSTPL CCCCCCCCCCCCCCC | 33.30 | 22167270 | |
| 27 | Phosphorylation | PESPVPSYASSTPLH CCCCCCCCCCCCCCC | 12.39 | 22167270 | |
| 29 | Phosphorylation | SPVPSYASSTPLHVP CCCCCCCCCCCCCCC | 26.89 | 22167270 | |
| 30 | Phosphorylation | PVPSYASSTPLHVPV CCCCCCCCCCCCCCC | 26.35 | 22167270 | |
| 31 | Phosphorylation | VPSYASSTPLHVPVP CCCCCCCCCCCCCCC | 27.63 | 22167270 | |
| 47 | Phosphorylation | ALRMEEDSIRLPAHL CCCCCCCCCCCCCEE | 16.94 | 23312004 | |
| 60 | Phosphorylation | HLRLQPIYWSRDDVA EEEECCCCCCHHHHH | 12.19 | 22817900 | |
| 86 | Phosphorylation | LRPIDSNTFEMNGKA CCCCCCCCEEECCEE | 25.56 | 30631047 | |
| 98 | Phosphorylation | GKALLLLTKEDFRYR CEEEEEEEHHHHCCC | 32.15 | 30631047 | |
| 99 | Sumoylation | KALLLLTKEDFRYRS EEEEEEEHHHHCCCC | 56.08 | - | |
| 99 | Sumoylation | KALLLLTKEDFRYRS EEEEEEEHHHHCCCC | 56.08 | - | |
| 114 | Phosphorylation | PHSGDVLYELLQHIL CCCHHHHHHHHHHHH | 12.36 | 20068231 | |
| 131 | Phosphorylation | RKPRILFSPFFHPGN CCCCEEEECCCCCCC | 19.83 | 23401153 | |
| 139 | Phosphorylation | PFFHPGNSIHTQPEV CCCCCCCCCCCCCEE | 22.97 | 23401153 | |
| 142 | Phosphorylation | HPGNSIHTQPEVILH CCCCCCCCCCEEEEC | 44.12 | 27251275 | |
| 161 | Phosphorylation | EDNCVQRTPRPSVDN CCCCCCCCCCCCCCC | 13.42 | 29255136 | |
| 165 | Phosphorylation | VQRTPRPSVDNVHHN CCCCCCCCCCCCCCC | 43.30 | 28464451 | |
| 175 | Phosphorylation | NVHHNPPTIELLHRS CCCCCCCHHHHHHCC | 28.48 | 27794612 | |
| 182 | Phosphorylation | TIELLHRSRSPITTN HHHHHHCCCCCCCCC | 26.77 | 27794612 | |
| 184 | Phosphorylation | ELLHRSRSPITTNHR HHHHCCCCCCCCCCC | 23.15 | 23401153 | |
| 187 | Phosphorylation | HRSRSPITTNHRPSP HCCCCCCCCCCCCCC | 25.57 | 27794612 | |
| 188 | Phosphorylation | RSRSPITTNHRPSPD CCCCCCCCCCCCCCC | 29.73 | 27794612 | |
| 193 | Phosphorylation | ITTNHRPSPDPEQRP CCCCCCCCCCHHHCC | 41.72 | 23401153 | |
| 203 | Phosphorylation | PEQRPLRSPLDNMIR HHHCCCCCHHHHHHH | 37.18 | 23401153 | |
| 213 | Phosphorylation | DNMIRRLSPAERAQG HHHHHHCCHHHHHCC | 21.91 | 23401153 | |
| 232 | Phosphorylation | QENNHQESYPLSVSP CCCCCCCCCCCCCCC | 26.02 | 23927012 | |
| 233 | Phosphorylation | ENNHQESYPLSVSPM CCCCCCCCCCCCCCC | 13.87 | 23927012 | |
| 236 | Phosphorylation | HQESYPLSVSPMENN CCCCCCCCCCCCCCC | 18.95 | 23927012 | |
| 238 | Phosphorylation | ESYPLSVSPMENNHC CCCCCCCCCCCCCCC | 18.36 | 23927012 | |
| 248 | Phosphorylation | ENNHCPASSESHPKP CCCCCCCCCCCCCCC | 21.56 | 23927012 | |
| 249 | Phosphorylation | NNHCPASSESHPKPS CCCCCCCCCCCCCCC | 45.27 | 23927012 | |
| 251 | Phosphorylation | HCPASSESHPKPSSP CCCCCCCCCCCCCCC | 47.22 | 23927012 | |
| 256 | Phosphorylation | SESHPKPSSPRQEST CCCCCCCCCCCCCCC | 60.13 | 23927012 | |
| 257 | Phosphorylation | ESHPKPSSPRQESTR CCCCCCCCCCCCCCC | 32.40 | 23927012 | |
| 271 | Phosphorylation | RVIQLMPSPIMHPLI CEEEECCCCCCCCHH | 17.06 | 29255136 | |
| 284 | Phosphorylation | LILNPRHSVDFKQSR HHCCCCCCCCCCHHH | 25.35 | 26657352 | |
| 288 | Ubiquitination | PRHSVDFKQSRLSED CCCCCCCCHHHCCCC | 42.79 | - | |
| 288 | Sumoylation | PRHSVDFKQSRLSED CCCCCCCCHHHCCCC | 42.79 | 28112733 | |
| 290 | Phosphorylation | HSVDFKQSRLSEDGL CCCCCCHHHCCCCCC | 35.46 | 23401153 | |
| 293 | Phosphorylation | DFKQSRLSEDGLHRE CCCHHHCCCCCCCCC | 32.31 | 23401153 | |
| 302 | Ubiquitination | DGLHREGKPINLSHR CCCCCCCCCCCCCCH | 37.66 | 19608861 | |
| 302 | Sumoylation | DGLHREGKPINLSHR CCCCCCCCCCCCCCH | 37.66 | 28112733 | |
| 302 | Acetylation | DGLHREGKPINLSHR CCCCCCCCCCCCCCH | 37.66 | 19608861 | |
| 307 | Phosphorylation | EGKPINLSHREDLAY CCCCCCCCCHHHHHH | 18.93 | 28674419 | |
| 314 | Phosphorylation | SHREDLAYMNHIMVS CCHHHHHHCCCEEEE | 13.02 | 22817900 | |
| 321 | Phosphorylation | YMNHIMVSVSPPEEH HCCCEEEECCCCHHH | 10.25 | 30266825 | |
| 323 | Phosphorylation | NHIMVSVSPPEEHAM CCEEEECCCCHHHCC | 27.51 | 30266825 | |
| 384 | Ubiquitination | ARLWGNHKNRTNMTY HHHHCCCCCCCCCCH | 52.72 | - | |
| 393 | Ubiquitination | RTNMTYEKMSRALRH CCCCCHHHHHHHHHH | 31.59 | - | |
| 395 | Phosphorylation | NMTYEKMSRALRHYY CCCHHHHHHHHHHHH | 26.01 | 24719451 | |
| 401 | Phosphorylation | MSRALRHYYKLNIIR HHHHHHHHHHHCEEE | 8.89 | 22817900 | |
| 402 | Phosphorylation | SRALRHYYKLNIIRK HHHHHHHHHHCEEEC | 11.68 | 22817900 | |
| 403 | Sumoylation | RALRHYYKLNIIRKE HHHHHHHHHCEEECC | 28.08 | 28112733 | |
| 403 | Ubiquitination | RALRHYYKLNIIRKE HHHHHHHHHCEEECC | 28.08 | - | |
| 421 | Sumoylation | RLLFRFMKTPDEIMS EEEEEECCCHHHHHC | 54.95 | - | |
| 421 | Sumoylation | RLLFRFMKTPDEIMS EEEEEECCCHHHHHC | 54.95 | 28112733 | |
| 421 | Ubiquitination | RLLFRFMKTPDEIMS EEEEEECCCHHHHHC | 54.95 | - | |
| 422 | Phosphorylation | LLFRFMKTPDEIMSG EEEEECCCHHHHHCC | 24.96 | 28450419 | |
| 431 | Phosphorylation | DEIMSGRTDRLEHLE HHHHCCCCHHHHHHH | 29.06 | 27251275 | |
| 439 | Phosphorylation | DRLEHLESQELDEQI HHHHHHHHHHHHHHH | 35.00 | 30108239 | |
| 447 | Phosphorylation | QELDEQIYQEDEC-- HHHHHHHHHHHCC-- | 12.92 | 28796482 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 17 | Y | Phosphorylation | Kinase | PDGFRB | P09619 | PSP |
| 22 | S | Phosphorylation | Kinase | MAPK14 | Q16539 | GPS |
| 27 | Y | Phosphorylation | Kinase | PDGFRB | P09619 | PSP |
| 213 | S | Phosphorylation | Kinase | MAPK3 | P27361 | GPS |
| 257 | S | Phosphorylation | Kinase | MAPK3 | P27361 | GPS |
| 257 | S | Phosphorylation | Kinase | P38A | Q16539 | PSP |
| - | K | Ubiquitination | E3 ubiquitin ligase | ICP0 | P08393 | PMID:32416261 |
| Modified Location | Modified Residue | Modification | Function | Reference |
|---|---|---|---|---|
| 257 | S | Phosphorylation |
| 12435397 |
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ETV6_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| GAB2_HUMAN | GAB2 | physical | 15143164 | |
| ETV6_HUMAN | ETV6 | physical | 9695962 | |
| GRB2_HUMAN | GRB2 | physical | 15143164 | |
| CRKL_HUMAN | CRKL | physical | 15143164 | |
| ACTS_HUMAN | ACTA1 | physical | 9695962 | |
| KAT5_HUMAN | KAT5 | physical | 12737628 | |
| FLI1_HUMAN | FLI1 | physical | 9651344 | |
| ETV6_HUMAN | ETV6 | physical | 9651344 | |
| FBXL6_HUMAN | FBXL6 | physical | 18426905 | |
| LMBL1_HUMAN | L3MBTL1 | physical | 12588862 | |
| SIN3A_HUMAN | SIN3A | physical | 11439334 | |
| HDAC3_HUMAN | HDAC3 | physical | 11439334 | |
| NCOR1_HUMAN | NCOR1 | physical | 11001911 | |
| UBC9_HUMAN | UBE2I | physical | 10377438 | |
| SUMO1_HUMAN | SUMO1 | physical | 11078523 | |
| SOCS1_HUMAN | SOCS1 | physical | 11314018 | |
| ETV6_HUMAN | ETV6 | physical | 12626745 | |
| AP1M1_HUMAN | AP1M1 | physical | 25416956 | |
| NTAQ1_HUMAN | WDYHV1 | physical | 25416956 | |
| LRP6_HUMAN | LRP6 | physical | 26186194 | |
| LRP5_HUMAN | LRP5 | physical | 26186194 | |
| NID2_HUMAN | NID2 | physical | 26186194 | |
| NID2_HUMAN | NID2 | physical | 28514442 | |
| LRP5_HUMAN | LRP5 | physical | 28514442 | |
| LRP6_HUMAN | LRP6 | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| Note=A chromosomal aberration involving ETV6 is found in a form of chronic myelomonocytic leukemia (CMML). Translocation t(5 | ||||||
| 12)(q33 | ||||||
| p13) with PDGFRB. It is characterized by abnormal clonal myeloid proliferation and by progression to acute myelogenous leukemia (AML). | ||||||
| 131440 | ||||||
| 601626 | Leukemia, acute myelogenous (AML) | |||||
| Note=A chromosomal aberration involving ETV6 is found in acute lymphoblastic leukemia. Translocation t(9 | ||||||
| 12)(p13 | ||||||
| p13) with PAX5. | ||||||
| 616216 | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-11 AND LYS-302, AND MASSSPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-16; THR-18 AND SER-22,AND MASS SPECTROMETRY. | |
| "Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-16; SER-22 AND SER-213,AND MASS SPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-18 AND SER-22, AND MASSSPECTROMETRY. | |
| "Functional regulation of TEL by p38-induced phosphorylation."; Arai H., Maki K., Waga K., Sasaki K., Nakamura Y., Imai Y.,Kurokawa M., Hirai H., Mitani K.; Biochem. Biophys. Res. Commun. 299:116-125(2002). Cited for: PHOSPHORYLATION AT SER-22 AND SER-257, AND MUTAGENESIS OF SER-213;SER-238 AND SER-257. | |